Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 3—March 2024
Research

Expansion of Neisseria meningitidis Serogroup C Clonal Complex 10217 during Meningitis Outbreak, Burkina Faso, 2019

Joann F. Kekeisen-ChenComments to Author , Felix T. Tarbangdo, Shalabh Sharma, Daya Marasini, Henju Marjuki, Janelle L. Kibler, Heather E. Reese, Seydou Ouattara, Flavien H. Ake, Issaka Yameogo, Issa Ouedraogo, Emmanuel Seini, Robert L. Zoma, Issa Tonde, Mahamoudou Sanou, Ryan T. Novak1, and Lucy A. McNamara1
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.F. Kekeisen-Chen, S. Sharma, D. Marasini, H. Marjuki, J.L. Kibler, H.E. Reese, R.T. Novak, L.A. McNamara); Davycas International, Ouagadougou, Burkina Faso (F.T. Tarbangdo, F.H. Ake, R.L. Zoma); Ministère de la Santé, Ouagadougou (S. Ouattara, I. Yameogo, I. Ouedraogo, E. Seini); Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Ouagadougou (I. Tonde, M. Sanou); Université Joseph Ki-Zerbo, Ouagadougou (I. Tonde, M. Sanou)

Main Article

Figure 4

Age distribution of patients with suspected and confirmed meningitis in study of expansion of NmC clonal complex 10217 during meningitis outbreak, Burkina Faso, January 28–May 5, 2019. Data are from districts of Diapaga, Sebba, Dori, Bogandé, Sebba, and Gayeri, Colors indicate the confirmed cause of meningitis; black line indicates number of suspected cases for each age group. The number of suspected cases includes 3 cases that met the definition of a probable case as previously described (18). NmC, Neisseria meningitidis serogroup C; NmX, N. meningitidis serogroup X.

Figure 4. Age distribution of patients with suspected and confirmed meningitis in study of expansion of NmC clonal complex 10217 during meningitis outbreak, Burkina Faso, January 28–May 5, 2019. Data are from districts of Diapaga, Sebba, Dori, Bogandé, Sebba, and Gayeri, Colors indicate the confirmed cause of meningitis; black line indicates number of suspected cases for each age group. The number of suspected cases includes 3 cases that met the definition of a probable case as previously described (18). NmC, Neisseria meningitidis serogroup C; NmX, N. meningitidis serogroup X.

Main Article

References
  1. Diallo  AO, Kiemtoré  T, Bicaba  BW, Medah  I, Tarbangdo  TF, Sanou  S, et al. Development and implementation of a cloud-based meningitis surveillance and specimen tracking system in Burkina Faso, 2018. J Infect Dis. 2019;220(Suppl 4):S198–205. DOIPubMedGoogle Scholar
  2. Patel  JC, Soeters  HM, Diallo  AO, Bicaba  BW, Kadadé  G, Dembélé  AY, et al.; MenAfriNet Consortium. MenAfriNet Consortium. MenAfriNet: a network supporting case-based meningitis surveillance and vaccine evaluation in the meningitis belt of Africa. J Infect Dis. 2019;220(Suppl 4):S148–54. DOIPubMedGoogle Scholar
  3. Greenwood  B. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93:341–53. DOIPubMedGoogle Scholar
  4. Lingani  C, Bergeron-Caron  C, Stuart  JM, Fernandez  K, Djingarey  MH, Ronveaux  O, et al. Meningococcal meningitis surveillance in the African meningitis belt, 2004–2013. Clin Infect Dis. 2015;61(Suppl 5):S410–5. DOIPubMedGoogle Scholar
  5. Alderson  MR, LaForce  FM, Sobanjo-Ter Meulen  A, Hwang  A, Preziosi  MP, Klugman  KP. Eliminating meningococcal epidemics from the African meningitis belt: the case for advanced prevention and control using next-generation neningococcal conjugate vaccines. J Infect Dis. 2019;220(Suppl 4):S274–8. DOIPubMedGoogle Scholar
  6. Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: revised recommendations from a WHO expert consultation. Wkly Epidemiol Rec. 2017;92:612–7.PubMedGoogle Scholar
  7. Whittle  HC, Evans-Jones  G, Onyewotu  I, Adjukiewicz  A, Turunen  U, Crockford  J, et al. Group-C meningococcal meningitis in the northern savanna of Africa. Lancet. 1975;305:1377. DOIGoogle Scholar
  8. Broome  CV, Rugh  MA, Yada  AA, Giat  L, Giat  H, Zeltner  JM, et al. Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bull World Health Organ. 1983;61:325–30.PubMedGoogle Scholar
  9. Koumare  B, Achtman  M, Cisse  M, Wang  JF, Giovanna  M, Doumbia  T. Etude antigénique de 337 souches de Neisseria meningitidis isolées au Mali. Intérêt épidémiologique et vaccinal. Med Mal Infect. 1995;25:1132–6. DOIGoogle Scholar
  10. Chow  J, Uadiale  K, Bestman  A, Kamau  C, Caugant  DA, Shehu  A, et al. Invasive meningococcal meningitis serogroup C outbreak in northwest Nigeria, 2015—third consecutive outbreak of a new strain. PLoS Curr. 2016;8:ecurrents.outbreaks.06d10b6b4e690917d8b0a04268906143.
  11. Funk  A, Uadiale  K, Kamau  C, Caugant  DA, Ango  U, Greig  J. Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013–14. PLoS Curr. 2014;6:ecurrents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518.
  12. Sidikou  F, Zaneidou  M, Alkassoum  I, Schwartz  S, Issaka  B, Obama  R, et al.; MenAfriNet consortium. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data. Lancet Infect Dis. 2016;16:1288–94. DOIPubMedGoogle Scholar
  13. Nnadi  C, Oladejo  J, Yennan  S, Ogunleye  A, Agbai  C, Bakare  L, et al. Large outbreak of Neisseria meningitidis serogroup C—Nigeria, December 2016–June 2017. MMWR Morb Mortal Wkly Rep. 2017;66:1352–6. DOIPubMedGoogle Scholar
  14. Kretz  CB, Retchless  AC, Sidikou  F, Issaka  B, Ousmane  S, Schwartz  S, et al.; Niger Response Team. Whole-genome characterization of epidemic Neisseria meningitidis serogroup C and resurgence of serogroup W, Niger, 2015. Emerg Infect Dis. 2016;22:1762–8. DOIPubMedGoogle Scholar
  15. Brynildsrud  OB, Eldholm  V, Bohlin  J, Uadiale  K, Obaro  S, Caugant  DA. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa. Proc Natl Acad Sci U S A. 2018;115:5510–5. DOIPubMedGoogle Scholar
  16. World Health Organization. WHO and partners provide vaccines to control meningitis C in Nigeria. April 13, 2017 [cited 2022 Feb 10]. https://www.who.int/news/item/13-04-2017-who-and-partners-provide-vaccines-to-control-meningitis-c-in-nigeria
  17. Novak  RT, Kambou  JL, Diomandé  FV, Tarbangdo  TF, Ouédraogo-Traoré  R, Sangaré  L, et al. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis. 2012;12:757–64. DOIPubMedGoogle Scholar
  18. World Health Organization. Standard operating procedures for surveillance of meningitis preparedness and response to epidemics in Africa. October 2018 [cited 2022 Feb 10]. https://apps.who.int/iris/bitstream/handle/10665/312141/9789290234241-eng.pdf
  19. Itsko  M, Retchless  AC, Joseph  SJ, Norris Turner  A, Bazan  JA, Sadji  AY, et al. Full molecular typing of Neisseria meningitidis directly from clinical specimens for outbreak investigation. J Clin Microbiol. 2020;58:e01780–20. DOIPubMedGoogle Scholar
  20. Dolan Thomas  J, Hatcher  CP, Satterfield  DA, Theodore  MJ, Bach  MC, Linscott  KB, et al. sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS One. 2011;6:e19361. DOIPubMedGoogle Scholar
  21. Katz  S, Townsend-Payne  K, Louth  J, Lee-Jones  L, Trotter  C, Dan Dano  I, et al.; MenAfriCar Consortium. Validation and use of a serum bactericidal antibody assay for Neisseria meningitidis serogroup X in a seroprevalence study in Niger, West Africa. Vaccine. 2022;40:6042–7. DOIPubMedGoogle Scholar
  22. World Health Organization. Control of epidemic meningococcal disease. WHO practical guidelines. 2nd edition. March 22, 1998 [cited 2022 Feb 10]. https://www.who.int/publications/i/item/control-of-epidemic-meningococcal-disease
  23. Teyssou  R, Muros-Le Rouzic  E. Meningitis epidemics in Africa: a brief overview. Vaccine. 2007;25(Suppl 1):A3–7. DOIPubMedGoogle Scholar
  24. Mueller  JE, Gessner  BD. A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt. Int J Infect Dis. 2010;14:e553–9 . DOIPubMedGoogle Scholar
  25. World Health Organization Regional Office for Africa. Enhanced surveillance of meningitis in Africa, Republic of Congo, 2020–2023 [cited 2023 Aug 1]. https://app.powerbi.com/view?r=eyJrIjoiMzExZTUzZDAtMmQ5Ni00YjkxLWFmZmItODljOWZhOTMyM2Y3IiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9
  26. Sultan  B, Labadi  K, Guégan  JF, Janicot  S. Climate drives the meningitis epidemics onset in west Africa. PLoS Med. 2005;2:e6. DOIPubMedGoogle Scholar
  27. Molesworth  AM, Cuevas  LE, Connor  SJ, Morse  AP, Thomson  MC. Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis. 2003;9:1287–93. DOIPubMedGoogle Scholar
  28. Palmgren  H. Meningococcal disease and climate. Glob Health Action. 2009;2:1. DOIPubMedGoogle Scholar
  29. Norwegian Refugee Council. Burkina Faso: almost 2 million people displaced amid worst food crisis in a decade. Sep 5, 2022 [cited 2022 Oct 5]. https://www.nrc.no/news/2022/september/burkina-faso-almost-2-million-people--now-displaced-amid-worst-food-crisis-in-a-decad
  30. World Health Organization. Assessing and improving the accuracy of target population estimates for immunization coverage. 2015 [cited 2022 Jun 1]. https://www.who.int/publications/m/item/assessing-and-improving-the-accuracy-of-target-population-estimates-for-immunization-coverage
  31. Nigeria Centre for Disease Control and Prevention. Cerebrospinal meningitis situation report, report 06, epidemiological week 23–26 (June 5–July 2, 2023) [cited 2023 Aug 1]. https://ncdc.gov.ng/diseases/sitreps/?cat=6&name=An%20Update%20of%20Meningitis%20Outbreak%20in%20Nigeria

Main Article

1These senior authors contributed equally to this article.

Page created: December 31, 2023
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external